Computer-aided detection of breast cancer: A cost-effectiveness study

Karen K Lindfors, Michele C. McGahan, C. Jonh Rosenquist, Gregory S. Hurlock

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: To analyze the cost-effectiveness of adding computer-aided detection (CAD) to a screening mammography program. Materials and Methods: A Markov model was developed to compare three hypothetical groups of women aged 40-79 years. The first group was composed of women undergoing mammographic screening without CAD; the second, of women undergoing mammographic screening with CAD; and the third, of women undergoing observation without screening. Cost-effectiveness was expressed as the marginal cost per year of life saved (MCYLS). MCYLS was calculated for screening mammography with CAD compared with screening mammography alone and for screening mammography alone compared with observation. Sensitivity analyses were performed by varying the cost of CAD, the rates of cancer detection with CAD, and the stage distribution of breast cancers diagnosed with CAD. Results: Adding CAD to a mammographic screening program resulted in a MCYLS of $19 058. The MCYLS of screening mammography alone compared with observation was $16 023. CAD increases the marginal effectiveness of screening by 29%; however, the marginal cost of screening is also increased by 34%. Varying the cost of CAD yields a linear increase in MCYLS from $8937 with CAD at $9 per case to $24 924 with CAD at $25 per case. The cost-effectiveness of CAD is dependent on the magnitude of the increase in cancer detection rates with CAD but is also affected by the stage distribution of cancers diagnosed with CAD. Conclusion: The MCYLS is 19% greater for CAD added to screening versus screening mammography alone but is still within the accepted range for cost-effectiveness.

Original languageEnglish (US)
Pages (from-to)710-717
Number of pages8
JournalRadiology
Volume239
Issue number3
DOIs
StatePublished - Jun 2006

Fingerprint

Cost-Benefit Analysis
Breast Neoplasms
Mammography
Costs and Cost Analysis
Observation
Neoplasms

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Computer-aided detection of breast cancer : A cost-effectiveness study. / Lindfors, Karen K; McGahan, Michele C.; Rosenquist, C. Jonh; Hurlock, Gregory S.

In: Radiology, Vol. 239, No. 3, 06.2006, p. 710-717.

Research output: Contribution to journalArticle

Lindfors, Karen K ; McGahan, Michele C. ; Rosenquist, C. Jonh ; Hurlock, Gregory S. / Computer-aided detection of breast cancer : A cost-effectiveness study. In: Radiology. 2006 ; Vol. 239, No. 3. pp. 710-717.
@article{6d472e5289aa4b619a8a240eb27d0713,
title = "Computer-aided detection of breast cancer: A cost-effectiveness study",
abstract = "Purpose: To analyze the cost-effectiveness of adding computer-aided detection (CAD) to a screening mammography program. Materials and Methods: A Markov model was developed to compare three hypothetical groups of women aged 40-79 years. The first group was composed of women undergoing mammographic screening without CAD; the second, of women undergoing mammographic screening with CAD; and the third, of women undergoing observation without screening. Cost-effectiveness was expressed as the marginal cost per year of life saved (MCYLS). MCYLS was calculated for screening mammography with CAD compared with screening mammography alone and for screening mammography alone compared with observation. Sensitivity analyses were performed by varying the cost of CAD, the rates of cancer detection with CAD, and the stage distribution of breast cancers diagnosed with CAD. Results: Adding CAD to a mammographic screening program resulted in a MCYLS of $19 058. The MCYLS of screening mammography alone compared with observation was $16 023. CAD increases the marginal effectiveness of screening by 29{\%}; however, the marginal cost of screening is also increased by 34{\%}. Varying the cost of CAD yields a linear increase in MCYLS from $8937 with CAD at $9 per case to $24 924 with CAD at $25 per case. The cost-effectiveness of CAD is dependent on the magnitude of the increase in cancer detection rates with CAD but is also affected by the stage distribution of cancers diagnosed with CAD. Conclusion: The MCYLS is 19{\%} greater for CAD added to screening versus screening mammography alone but is still within the accepted range for cost-effectiveness.",
author = "Lindfors, {Karen K} and McGahan, {Michele C.} and Rosenquist, {C. Jonh} and Hurlock, {Gregory S.}",
year = "2006",
month = "6",
doi = "10.1148/radiol.2392050670",
language = "English (US)",
volume = "239",
pages = "710--717",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Computer-aided detection of breast cancer

T2 - A cost-effectiveness study

AU - Lindfors, Karen K

AU - McGahan, Michele C.

AU - Rosenquist, C. Jonh

AU - Hurlock, Gregory S.

PY - 2006/6

Y1 - 2006/6

N2 - Purpose: To analyze the cost-effectiveness of adding computer-aided detection (CAD) to a screening mammography program. Materials and Methods: A Markov model was developed to compare three hypothetical groups of women aged 40-79 years. The first group was composed of women undergoing mammographic screening without CAD; the second, of women undergoing mammographic screening with CAD; and the third, of women undergoing observation without screening. Cost-effectiveness was expressed as the marginal cost per year of life saved (MCYLS). MCYLS was calculated for screening mammography with CAD compared with screening mammography alone and for screening mammography alone compared with observation. Sensitivity analyses were performed by varying the cost of CAD, the rates of cancer detection with CAD, and the stage distribution of breast cancers diagnosed with CAD. Results: Adding CAD to a mammographic screening program resulted in a MCYLS of $19 058. The MCYLS of screening mammography alone compared with observation was $16 023. CAD increases the marginal effectiveness of screening by 29%; however, the marginal cost of screening is also increased by 34%. Varying the cost of CAD yields a linear increase in MCYLS from $8937 with CAD at $9 per case to $24 924 with CAD at $25 per case. The cost-effectiveness of CAD is dependent on the magnitude of the increase in cancer detection rates with CAD but is also affected by the stage distribution of cancers diagnosed with CAD. Conclusion: The MCYLS is 19% greater for CAD added to screening versus screening mammography alone but is still within the accepted range for cost-effectiveness.

AB - Purpose: To analyze the cost-effectiveness of adding computer-aided detection (CAD) to a screening mammography program. Materials and Methods: A Markov model was developed to compare three hypothetical groups of women aged 40-79 years. The first group was composed of women undergoing mammographic screening without CAD; the second, of women undergoing mammographic screening with CAD; and the third, of women undergoing observation without screening. Cost-effectiveness was expressed as the marginal cost per year of life saved (MCYLS). MCYLS was calculated for screening mammography with CAD compared with screening mammography alone and for screening mammography alone compared with observation. Sensitivity analyses were performed by varying the cost of CAD, the rates of cancer detection with CAD, and the stage distribution of breast cancers diagnosed with CAD. Results: Adding CAD to a mammographic screening program resulted in a MCYLS of $19 058. The MCYLS of screening mammography alone compared with observation was $16 023. CAD increases the marginal effectiveness of screening by 29%; however, the marginal cost of screening is also increased by 34%. Varying the cost of CAD yields a linear increase in MCYLS from $8937 with CAD at $9 per case to $24 924 with CAD at $25 per case. The cost-effectiveness of CAD is dependent on the magnitude of the increase in cancer detection rates with CAD but is also affected by the stage distribution of cancers diagnosed with CAD. Conclusion: The MCYLS is 19% greater for CAD added to screening versus screening mammography alone but is still within the accepted range for cost-effectiveness.

UR - http://www.scopus.com/inward/record.url?scp=33744814928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744814928&partnerID=8YFLogxK

U2 - 10.1148/radiol.2392050670

DO - 10.1148/radiol.2392050670

M3 - Article

C2 - 16569787

AN - SCOPUS:33744814928

VL - 239

SP - 710

EP - 717

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -